A new trading day began on August 04, 2022, with Veracyte Inc. (NASDAQ: VCYT) stock priced at $25.59, up 10.42% from the previous day of trading. During the day, the shares moved up to $27.77 and dropped to $25.19 before settling in for the closing price of $25.05. VCYT’s price has ranged from $14.85 to $54.13 over the past 52 weeks.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Sponsored
A company in the Healthcare sector has jumped its sales by 27.50% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -69.70%. With a float of $70.78 million, this company’s outstanding shares have now reached $71.23 million.
In an organization with 761 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +57.84, operating margin of -26.87, and the pretax margin is -37.20.
Veracyte Inc. (VCYT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The most recent insider transaction that took place on Jun 14, was worth 141,846. In this transaction Director of this company sold 8,720 shares at a rate of $16.27, taking the stock ownership to the 2,000 shares. Before that another transaction happened on Jun 10, when Company’s Chief Executive Officer bought 60,000 for $16.33, making the entire transaction worth $980,094. This insider now owns 159,761 shares in total.
Veracyte Inc. (VCYT) Latest Financial update
In its latest quarterly report, released on 3/30/2022, the company reported earnings of -$0.2 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -34.42 while generating a return on equity of -9.96. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -69.70% per share during the next fiscal year.
Veracyte Inc. (NASDAQ: VCYT) Trading Performance Indicators
Here are Veracyte Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.69, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Veracyte Inc. (VCYT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.92 million. That was inferior than the volume of 0.95 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 65.06%. Additionally, its Average True Range was 1.89.
During the past 100 days, Veracyte Inc.’s (VCYT) raw stochastic average was set at 77.59%, which indicates a significant decrease from 88.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.70% in the past 14 days, which was lower than the 90.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $21.68, while its 200-day Moving Average is $29.68. However, in the short run, Veracyte Inc.’s stock first resistance to watch stands at $28.56. Second resistance stands at $29.45. The third major resistance level sits at $31.14. If the price goes on to break the first support level at $25.98, it is likely to go to the next support level at $24.29. The third support level lies at $23.40 if the price breaches the second support level.
Veracyte Inc. (NASDAQ: VCYT) Key Stats
With a market capitalization of 1.97 billion, the company has a total of 71,445K Shares Outstanding. Currently, annual sales are 219,510 K while annual income is -75,560 K. The company’s previous quarter sales were 67,780 K while its latest quarter income was -14,460 K.
